Skip to content

A randomized controlled study of intrauterine perfusion of autologous adipose stem cell sheet suspension in the treatment of intrauterine adhesions

A randomized controlled study of intrauterine perfusion of autologous adipose stem cell sheet suspension in the treatment of intrauterine adhesions

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052229
Enrollment
Unknown
Registered
2021-10-23
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine adhesion

Interventions

Group 1:Intrauterine perfusion with adipose-derived stem cells
Group 2:Not injected with adipose-derived stem cells into cavity

Sponsors

The Second Affiliated Hospital of PLA Air Force Military Medical University (Tangdu Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as intrauterine adhesions by hysteroscopy; 2. Aged 20 to 40 years; 3. BMI 18-25Kg/m^2; 4. Undergoing hysteroscopic hysterotomy.

Exclusion criteria

Exclusion criteria: 1. Those who use anticoagulants or NSAIDs at least 10 days before surgery; 2. Those with serious diseases or serious dysfunction of important organs such as the heart, liver, kidney, lung, and brain; 3. Those with local or systemic infection and uncontrolled other contraindications for intrauterine adhesion separation; 4. Unicornuate uterus, bicornuate uterus, residual horn uterus, primordial uterus or immature uterus; 5. Severe endometritis.

Design outcomes

Primary

MeasureTime frame
Ongoing pregnancy rate;

Secondary

MeasureTime frame
Menstrual improvement rate;The time after operation for the uterine cavity to return to normal;Endometrial thickness during ovulation;Live birth rate;

Countries

China

Contacts

Public ContactXiao Xifeng

The Second Affiliated Hospital of PLA Air Force Military Medical University (Tangdu Hospital)

xxfeng926@163.com+86 18149363396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026